You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Moderna
Biotech
mRNA
Moderna Vaccine
Topics

Advertisement

Moderna

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

US drug regulator to review Moderna's mRNA flu vaccine after rejection Anadolu Agency 16:37 Tue, 07 Apr

Anadolu Agency 16:37 Tue, 07 Apr

European commission approves mRNA's COVID-19-Influenza combo shot Zacks 14h

Zacks 14h

mRNA Coronavirus Vaccine

Moderna Vaccine

Pivotal trial of Moderna's H5N1 bird flu jab gets underway pharmaphorum 19h

pharmaphorum 19h

Advertisement

Advertisement

Bank of America flags international opportunities as key growth driver for Moderna Proactive Investors (US) 18:07 Wed, 08 Apr

Proactive Investors (US) 18:07 Wed, 08 Apr

Stock Markets (World) Moderna Vaccine

Bank of America

What's pushing Moderna stock higher today? Benzinga 3d

Benzinga 3d

Moderna (MRNA) stock declines while market improves: Some information for investors Zacks 23:58 Thu, 09 Apr

Zacks 23:58 Thu, 09 Apr

S&P 500 Stock Markets (World)

Stock Market (US)

Advertisement

Advertisement

Latest

In the last 8 hours

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing Zacks 00:00

Yesterday

European Commission Approves MRNA's COVID-19-Influenza Combo Shot Zacks 17:23 Wed, 22 Apr

Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss HealthDay 16:01 Wed, 22 Apr

Moderna continues bird flu vax study, but limits work in the U.S. STAT 12:54 Wed, 22 Apr

Pivotal trial of Moderna's H5N1 bird flu jab gets underway pharmaphorum 11:35 Wed, 22 Apr

Moderna launches mRNA bird flu vaccine trial after HHS cancels funding The Washington Post 02:23 Wed, 22 Apr

expert reaction to Moderna / NIHR launch of new human vaccine trial: mRNA vaccine candidate against H5N1 bird flu Science Media Centre 00:19 Wed, 22 Apr

Tuesday

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth The Motley Fool 21:58 Tue, 21 Apr

Europe Clears First Flu/Covid Combo Shot From Moderna Benzinga 19:01 Tue, 21 Apr

Monday

GSK, Moderna Both Ordered To Provide More Info In Vax Fight Law360 20:54 Mon, 20 Apr

Advertisement

Advertisement

Advertisement

Advertisement

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna